C12Y 301/01007
Acetylcholinesterase
Official title: Acetylcholinesterase (3.1.1.7)
C12Y301/01007 (Acetylcholinesterase) appears on 44 US grants and 60 published applications in this corpus.
Search patents in C12Y- Granted patents
- 44
- Published applications
- 60
- Assignees
- 46
- Inventors
- 137
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 1 | 5 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 5 |
| 2010 | 3 | 0 |
| 2011 | 0 | 3 |
| 2012 | 2 | 2 |
| 2013 | 1 | 3 |
| 2014 | 1 | 2 |
| 2015 | 1 | 3 |
| 2016 | 1 | 5 |
| 2017 | 1 | 4 |
| 2018 | 3 | 1 |
| 2019 | 5 | 7 |
| 2020 | 3 | 3 |
| 2021 | 6 | 3 |
| 2022 | 2 | 2 |
| 2023 | 0 | 1 |
| 2024 | 3 | 4 |
| 2025 | 1 | 1 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cells for enhanced production of adeno-associated virus17 Mar 2026US 12,577,539 B2The Regents of the University of California
- Bioactive nanoparticle compositions and methods for making same10 Feb 2026US 12,544,456 B2Aqua Regenerative Therapies LLC
- Recombinant protein produced from cholinesterase gene derived from Pseudomonas aeruginosa and the composition comprising the same for treating or preventing a neurological disease3 Jun 2025US 12,318,435 B2Skypeach Co., Ltd
- Neurodegenerative disorders12 Nov 2024US 12,139,729 B2Neuro-Bio Ltd
- Method for inhibiting enzyme activity using Boscia senegalensis22 Oct 2024US 12,121,555 B1King Faisal University
- Lateral flow device for diagnosing alzheimer's disease using the t14 peptide27 Aug 2026US 2026/0251650 A1
- Methods for quantitating viral capsids30 Apr 2026US 2026/0117275 A1Sartorius BioAnalytical Instruments, Inc.
- Methods for quantitating viral capsids3 Apr 2025US 2025/0110119 A1Sartorius BioAnalytical Instruments, Inc.
- Peptide t14 for braak staging7 Nov 2024US 2024/0369578 A1
- Cyclic peptides from the c-terminus of acetylcholinesterase for treatment of skin disorders and for cosmetical use27 Jun 2024US 2024/0207373 A1Neuro-Bio Ltd
Most cited
By later US patents
- Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof118US 7,456,154 B2Yissum Research Development Company of the Hebrew University of Jerusalem · 2008
- Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them116US 5,891,725 AYissum Research Development Co. of the Hebrew Univ. of Jerusalem · 1999
- Conjugates of agents and transglutaminase substrate linking molecules22US 6,919,076 B1Pericor Science, Inc. · 2005
- Methods and compositions for pain management16US 6,764,831 B2Proteome Sciences plc · 2004
- RNAi-mediated inhibition of ocular targets15US 7,592,324 B2Alcon Inc. · 2009